Rajiv I. Modi

Rajiv Modi

Dr. Rajiv I. Modi, Chairman and Managing Director, Cadila Pharmaceuticals is a Ph.D. in Biological Science from the University of Michigan, Ann Arbor, USA. He is M.Sc. in Biochemical Engineering from University College, London and B.Tech. in Chemical Engineering from Indian Institute of Technology (IIT), Bombay, India.

Dr. Modi joined the Board of Directors of Cadila Laboratories in 1991; restructured in 1995 and re-christened as Cadila Pharmaceuticals Limited (CPL). At present, Dr. Modi is Chairman and Managing Director of Cadila Pharmaceuticals and Chairman of Casil Industries Limited (CIL), Karnavati Engineering Limited (KEL), CPL Biologicals Private Limited (CPLB) and IRM Limited (IRM). He is also a Director on the board of other Cadila Pharmaceuticals Group Companies.

Upon assuming leadership of Cadila Pharmaceuticals, Dr. Rajiv I. Modi charted a multi-pronged approach for Cadila Pharmaceuticals’ corporate growth. Envisioning a global presence for the group, Dr. Modi played a pivotal role in establishing marketing set-up and subsidiaries of Cadila Pharmaceuticals across the shores. Today Cadila Pharmaceuticals has a strong global presence with operations in the USA, Japan, CIS, and Africa; with its first overseas formulations manufacturing unit at Addis Ababa, Ethiopia. Cadila Pharmaceuticals has affiliations with leading companies and manufacturers across the globe, and has imbibed world-class technologies in its operations.

At Cadila Pharmaceuticals, there is immense focus on research. Being a Biotechnologist himself, Dr. Modi has played a major role in developing the Biotechnology Division at Cadila Pharmaceuticals into a strong Research and Development unit, focusing on new developments and breakthrough innovations. Collaborative research in Biotechnology is being carried out at various National and International Research Laboratories like IMTECH, Chandigarh; IISc, Bangalore; NII and CBT, New Delhi; ICGEB, New Delhi & Trieste, Italy.

In keeping with Cadila Pharmaceuticals’ vision to be a global company, Dr. Modi has brought a cutting edge to all the operations within the Cadila Pharmaceuticals group – be it Marketing, Human Resources, Technological upgradations, infrastructure building or sharpening the core competencies of the group. He has led Cadila Pharmaceuticals to enter into joint ventures/strategic collaborations with Apollo Hospitals (Gujarat), India; Bactiguard AB, Sweden; Helperby Therapeutics plc, UK; Novavax Inc., USA; Pergamum AB, Sweden; and Stemcyte Inc. USA.

Dr. Modi has also been actively participating in the exemplary development of the state of Gujarat. As a part of Vibrant Gujarat celebrations, he led the industrial delegation from the state to Japan in 2009 to strengthen the business ties between the two countries. Eventually, Japan became the partner country in Vibrant Gujarat. He has also been nominated to the Steering Committee of Gujarat Chamber of Commerce and Industry. He was Chairman of CII Gujarat State Council.

Dr. Modi is a member of The New York Academy of Sciences, USA; Genetic Society of America; American Society for Microbiology; Industrial Biotechnology Task Force, New Delhi; Technical Panel on Biotechnology, Gujarat; Indian Chemical Engineer, India and TIFAC. Dr. Modi has also been elected as Fellow of Indian National Academy of Engineering, New Delhi. This elite academy has prominent industry leaders, academicians and scientists amongst its Fellows.